Glabellar Rhytides Clinical Trial
Official title:
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Forehead and Glabellar Facial Rhytides
This is a safety and efficacy study of onabotulinumtoxinA in subjects with forehead and glabellar facial rhytides (frown lines).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02261493 -
A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
|
Phase 3 | |
Completed |
NCT00752050 -
Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows
|
Phase 3 | |
Completed |
NCT01814670 -
Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines
|
Phase 4 | |
Completed |
NCT00752297 -
Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows
|
Phase 3 | |
Completed |
NCT00752258 -
A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows
|
Phase 3 |